Table 1.
Patient Characteristics by Pre-HCT Blood Glucose Trajectory Group. Percentage composition does not include missing category
|
|
Pre-Transplant Blood Glucose Trajectory Group
|
P 1 | |||
|---|---|---|---|---|---|
|
All
N=404 |
1
N=317 |
2
N=67 |
3
N=20 |
||
| Age at Transplant Median (Min – Max) |
53.0 (0.1 – 75.8) | 52.9 (0.1 – 75.8) | 52.9 (1.0 – 71.5) | 56.6 (28.0 – 70.0) | 0.34742 |
| BMI Median (Min – Max) |
12 Missing 25.8 (12.5 – 85.8) |
10 Missing 25.6 (12.5 – 85.8) |
2 Missing 26.6 (15.8 – 57.2) |
0 Missing 26.7 (18.7, 37.9) |
0.09732 |
| Gender Female Male |
175 (43%) 229 (57%) |
143 (45%) 174 (55%) |
28 (42%) 39 (58%) |
4 (20%) 16 (80%) |
0.0804 |
| Race Caucasian African American Hispanic/Latino Asian/Native American/Other |
14 Missing 150 (38%) 86 (22%) 32 (8%) 122 (31%) |
10 Missing 126 (41%) 75 (24%) 22 (7%) 84 (27%) |
4 Missing 19 (30%) 8 (13%) 8 (13%) 28 (44%) |
0 Missing 5 (25%) 3 (15%) 2 (10%) 10 (50%) |
0.0132* |
| Ethnicity Hispanic Non-Hispanic |
138 Missing 71 (27%) 195 (73%) |
109 Missing 49 (24%) 159 (76%) |
24 Missing 14 (33%) 29 (67%) |
5 Missing 8 (53%) 7 (47%) |
0.0268* |
| Diabetic | 92 (23%) | 45 (14%) | 29 (43%) | 18 (90%) | <.0001* |
| GVHD | 207 (51%) | 160 (50%) | 37 (55%) | 10 (50%) | 0.7739 |
| ICU Stay | 44 (11%) | 32 (10%) | 12 (18%) | 0 (0%) | 0.0497* |
| TPN Administered | 96 (24%) | 76 (24%) | 14 (21%) | 6 (30%) | 0.6902 |
| Steroids Administered | 145 (36%) | 102 (32%) | 38 (57%) | 5 (25%) | 0.0004* |
| Immunosuppressants Administered | 222 (55%) | 166 (52%) | 47 (70%) | 9 (45%) | 0.0192* |
| Endocrinology Consult | 1 Missing 205 (51%) |
1 Missing 152 (48%) |
0 Missing 36 (54%) |
0 Missing 17 (85%) |
0.0039* |
| Bone Marrow Transplant Type Related Allogeneic Unrelated Allogeneic Autologous |
1 Missing 94 (23%) 134 (33%) 175 (43%) |
1 Missing 68 (22%) 100 (32%) 148 (47%) |
0 Missing 21 (31%) 29 (43%) 17 (25%) |
0 Missing 5 (25%) 5 (25%) 10 (50%) |
0.0258* |
| Primary Diagnosis Multiple Myeloma Acute Myeloid Leukemia (AML) Acute Lymphocytic Leukemia (ALL) Hodgkin’s Lymphoma Non-Hodgkin’s Lymphoma Other |
0 Missing 69 (17%) 81 (20%) 34 (8%) 32 (8%) 87 (22%) 101 (25%) |
0 Missing 63 (20%) 57 (18%) 29 (9%) 23 (7%) 74 (23%) 71 (23%) |
0 Missing 6 (9%) 20 (30%) 5 (8%) 7 (10%) 8 (12%) 21 (31%) |
0 Missing 0 (0%) 4 (20%) 0 (0%) 2 (10%) 5 (25%) 9 (45%) |
|
1
Values of P were calculated by Chi-square test or Fisher’s exact test as appropriate, if not specified otherwise.
2
Values of P were calculated by Kruskal-Wallis test.
*
: p < 0.05.